These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6645778)

  • 1. Electric convulsive therapy (ECT) increases plasma and red blood cell haloperidol neuroleptic activities.
    Aoba A; Kakita Y; Yamaguchi N; Shido M; Shibata M; Kitani K; Hasegawa K
    Life Sci; 1983 Oct; 33(18):1797-803. PubMed ID: 6645778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redistribution of haloperidol after electroshock: experimental evidence.
    Shibata M; Aoba A; Kitani K; Kanai S; Sato Y; Kakita Y; Yamaguchi N; Hasegawa K
    Life Sci; 1989; 44(11):749-53. PubMed ID: 2927245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined electroconvulsive and neuroleptic therapy in schizophrenia refractory to neuroleptics.
    König P; Glatter-Götz U
    Schizophr Res; 1990; 3(5-6):351-4. PubMed ID: 1980828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid chromatographic determination of reduced haloperidol and haloperidol concentrations in packed red blood cells from humans.
    Vatassery GT; Herzan LA; Dysken MW
    J Anal Toxicol; 1990; 14(1):25-8. PubMed ID: 2314059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy.
    Nothdurfter C; Eser D; Schüle C; Zwanzger P; Marcuse A; Noack I; Möller HJ; Rupprecht R; Baghai TC
    World J Biol Psychiatry; 2006; 7(3):162-70. PubMed ID: 16861142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of age effect on plasma haloperidol neuroleptic levels in psychiatric patients.
    Aoba A; Kakita Y; Yamaguchi N; Shido M; Tsuneizumi T; Shibata M; Kitani K; Hasegawa K
    J Gerontol; 1985 May; 40(3):303-8. PubMed ID: 3989243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood levels of haloperidol and thioridazine during maintenance neuroleptic treatment of schizophrenic outpatients.
    Shvartsburd A; Sajadi C; Morton V; Mirabi M; Gordon J; Smith RC
    J Clin Psychopharmacol; 1984 Aug; 4(4):194-8. PubMed ID: 6470190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RBC and plasma levels of haloperidol and clinical response in schizophrenia.
    Smith RC; Vroulis G; Shvartsburd A; Allen R; Lewis N; Schoolar JC; Chojnacki M; Johnson R
    Am J Psychiatry; 1982 Aug; 139(8):1054-6. PubMed ID: 7091432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].
    Dutoit D; Thomas P; Leroux JM; Vaiga G; Pommery J; Cottencin O; Erb F; Goudemand M
    Encephale; 1995; 21(6):417-24. PubMed ID: 8674466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An exploratory evaluation of ECT in haloperidol-treated DSM-IIIR schizophreniform disorder.
    Sarkar P; Andrade C; Kapur B; Das P; Sivaramakrishna Y; Harihar C; Pandey A; Anand A; Dharmendra MS
    Convuls Ther; 1994 Dec; 10(4):271-8. PubMed ID: 7850397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term effect of combined ECT and neuroleptic therapy in treatment-resistant schizophrenia.
    Chanpattana W; Chakrabhand ML; Kongsakon R; Techakasem P; Buppanharun W
    J ECT; 1999 Jun; 15(2):129-39. PubMed ID: 10378152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic radioreceptor activity and clinical outcome in schizophrenia.
    Contreras S; Alexander H; Faber R; Bowden C
    J Clin Psychopharmacol; 1987 Apr; 7(2):95-8. PubMed ID: 3584527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between plasma and red blood cell neuroleptic levels, oral dosage, and clinical parameters in a chronic schizophrenic population.
    Dunlop SR; Shea PA; Hendrie HC
    Biol Psychiatry; 1982 Aug; 17(8):929-36. PubMed ID: 6126231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
    Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T
    J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction of serum neuroleptic activity for blood-to-brain distribution: a method that may render radioreceptor assay results comparable between neuroleptics.
    Young AS; Faraone SV; Brown WA
    J Clin Psychopharmacol; 1989 Oct; 9(5):361-3. PubMed ID: 2571620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electroconvulsive therapy for the treatment of neuroleptic malignant syndrome with psychotic symptoms: a report of five cases.
    Nisijima K; Ishiguro T
    J ECT; 1999 Jun; 15(2):158-63. PubMed ID: 10378156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma haloperidol levels drawn at neuroleptic threshold doses: a pilot study.
    McEvoy JP; Stiller RL; Farr R
    J Clin Psychopharmacol; 1986 Jun; 6(3):133-8. PubMed ID: 3711363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of haloperidol and reduced haloperidol in the plasma and blood of patients on depot haloperidol.
    Eyles DW; Whiteford HA; Stedman TJ; Pond SM
    Psychopharmacology (Berl); 1992; 106(2):268-74. PubMed ID: 1549652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Electroconvulsive therapy and schizophrenia. Update from the data of the literature].
    Joober R; Bennegadi Z; Olié JP; Lôo H
    Encephale; 1991; 17(4):267-72. PubMed ID: 1683628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of haloperidol reductase activity in red blood cells and reduced haloperidol/haloperidol ratios in plasma in oriental psychiatric patients.
    Shibasaki M; Someya T; Kato T; Noguchi T; Ishida N; Takahashi S
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(6):941-7. PubMed ID: 2277853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.